107 related articles for article (PubMed ID: 9240457)
1. Members of the family of IL-6-type cytokines activate Stat5a in various cell types.
Piekorz RP; Nemetz C; Hocke GM
Biochem Biophys Res Commun; 1997 Jul; 236(2):438-43. PubMed ID: 9240457
[TBL] [Abstract][Full Text] [Related]
2. Induction of differentiation by IL-6-type cytokines is impaired in myeloid leukaemia cells unable to activate Stat5a.
Piekorz RP; Hocke GM
Cytokine; 1997 Sep; 9(9):639-49. PubMed ID: 9325012
[TBL] [Abstract][Full Text] [Related]
3. bFGF and LIF signaling activates STAT3 in proliferating myoblasts.
Megeney LA; Perry RL; LeCouter JE; Rudnicki MA
Dev Genet; 1996; 19(2):139-45. PubMed ID: 8900046
[TBL] [Abstract][Full Text] [Related]
4. Transcription factor Stat5 is an early marker of differentiation of murine embryonic stem cells.
Nemetz C; Hocke GM
Differentiation; 1998 Mar; 62(5):213-20. PubMed ID: 9566306
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-2 family cytokines stimulate phosphorylation of the Pro-Ser-Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways.
Nagy ZS; Wang Y; Erwin-Cohen RA; Aradi J; Monia B; Wang LH; Stepkowski SM; Rui H; Kirken RA
J Leukoc Biol; 2002 Oct; 72(4):819-28. PubMed ID: 12377952
[TBL] [Abstract][Full Text] [Related]
6. Oncostatin M and interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells.
Klausen P; Pedersen L; Jurlander J; Baumann H
Oncogene; 2000 Jul; 19(32):3675-83. PubMed ID: 10951574
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional activation of the mouse peripherin gene by leukemia inhibitory factor: involvement of STAT proteins.
Lecomte MJ; Basseville M; Landon F; Karpov V; Fauquet M
J Neurochem; 1998 Mar; 70(3):971-82. PubMed ID: 9489716
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the activation status of Stat5a during LIF-induced differentiation of M1 myeloid leukemia cells.
Piekorz RP; Rinke R; Gouilleux F; Neumann B; Groner B; Hocke GM
Biochim Biophys Acta; 1998 Apr; 1402(3):313-23. PubMed ID: 9606990
[TBL] [Abstract][Full Text] [Related]
9. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
Song L; Turkson J; Karras JG; Jove R; Haura EB
Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
Kortylewski M; Heinrich PC; Mackiewicz A; Schniertshauer U; Klingmüller U; Nakajima K; Hirano T; Horn F; Behrmann I
Oncogene; 1999 Jun; 18(25):3742-53. PubMed ID: 10391682
[TBL] [Abstract][Full Text] [Related]
11. Regulation of IL-6 signaling by p53: STAT3- and STAT5-masking in p53-Val135-containing human hepatoma Hep3B cell lines.
Rayanade RJ; Ndubuisi MI; Etlinger JD; Sehgal PB
J Immunol; 1998 Jul; 161(1):325-34. PubMed ID: 9647240
[TBL] [Abstract][Full Text] [Related]
12. Differentiation responses of embryonic endothelium to leukemia inhibitory factor.
Paradis H; Arceci RJ; Adams LC; Gendron RL
Exp Cell Res; 1998 Apr; 240(1):7-15. PubMed ID: 9570916
[TBL] [Abstract][Full Text] [Related]
13. The effects of interleukin-6, leukemia inhibitory factor and interferon-gamma on STAT DNA binding and c-fos mRNA levels in cortical astrocytes and C6 glioma cells.
Jenab S; Quinones-Jenab V
Neuro Endocrinol Lett; 2002 Aug; 23(4):325-8. PubMed ID: 12195235
[TBL] [Abstract][Full Text] [Related]
14. Leukaemia inhibitory factor and interleukin 6 inhibit secretion of prolactin and growth hormone by rat pituitary MtT/SM cells.
Tomida M; Yoshida U; Mogi C; Maruyama M; Goda H; Hatta Y; Inoue K
Cytokine; 2001 May; 14(4):202-7. PubMed ID: 11448119
[TBL] [Abstract][Full Text] [Related]
15. Directly linked soluble IL-6 receptor-IL-6 fusion protein induces astrocyte differentiation from neuroepithelial cells via activation of STAT3.
Takizawa T; Yanagisawa M; Ochiai W; Yasukawa K; Ishiguro T; Nakashima K; Taga T
Cytokine; 2001 Mar; 13(5):272-9. PubMed ID: 11243705
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-9 (IL-9) induces cell growth arrest associated with sustained signal transducer and activator of transcription activation in lymphoma cells overexpressing the IL-9 receptor.
Demoulin JB; Van Snick J; Renauld JC
Cell Growth Differ; 2001 Mar; 12(3):169-74. PubMed ID: 11306517
[TBL] [Abstract][Full Text] [Related]
17. IL-2 and IL-7 induce heterodimerization of STAT5 isoforms in human peripheral blood T lymphoblasts.
Rosenthal LA; Winestock KD; Finbloom DS
Cell Immunol; 1997 Nov; 181(2):172-81. PubMed ID: 9398404
[TBL] [Abstract][Full Text] [Related]
18. The LIF response element of the alpha 2 macroglobulin gene confers LIF-induced transcriptional activation in embryonal stem cells.
Hocke GM; Cui MZ; Fey GH
Cytokine; 1995 Aug; 7(6):491-502. PubMed ID: 8580364
[TBL] [Abstract][Full Text] [Related]
19. LIF-induced STAT3 signaling in murine versus human embryonal carcinoma (EC) cells.
Schuringa JJ; van der Schaaf S; Vellenga E; Eggen BJ; Kruijer W
Exp Cell Res; 2002 Mar; 274(1):119-29. PubMed ID: 11855863
[TBL] [Abstract][Full Text] [Related]
20. Alternative signaling mechanism of leukemia inhibitory factor responsiveness in a differentiating embryonal carcinoma cell.
Takeda T; Kurachi H; Yamamoto T; Homma H; Adachi K; Morishige K; Miyake A; Murata Y
Endocrinology; 1997 Jul; 138(7):2689-96. PubMed ID: 9202205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
